期刊文献+

降钙素原对指导慢性阻塞性肺疾病急性加重期抗菌治疗的价值 被引量:3

Instruction value of procalcitonin in antibiotic therapy for chronic obstructive pulmonary diseases in acute exacerbation period
下载PDF
导出
摘要 目的观察降钙素原(PCT)对慢性阻塞性肺疾病急性加重期(AECOPD)指导抗菌治疗的应用价值。方法选择2011年10月~2013年2月我院收治的符合AECOPD诊断并于住院当日检测血清PCT>0.25μg/L患者87例,随机分为PCT组53例和常规治疗组34例。PCT组根据血清PCT水平指导抗菌治疗,PCT<0.25μg/L停用抗生素;常规治疗组根据患者临床表现、C反应蛋白、白细胞计数决定抗生素的应用。两组同时进行痰细菌学的检查。观察指标为抗菌治疗天数、住院天数、临床有效率、加重或死亡病例数等。结果 PCT组的抗菌治疗天数多在3~10 d;而常规治疗组大多超过14 d,有显著统计学差异(P<0.05);两组患者住院天数比较有统计学意义(P<0.05);二重感染发生病例数两组比较有统计学差异(P<0.05);两组临床有效率、加重或死亡率差异无统计学意义(P>0.05)。结论监测PCT水平对诊治AECOPD可获得更好的疗效,减少不必要的抗生素使用,降低二重感染机会。 Objective To observe the instruction value of procalcitonin(PCT) in antibiotic therapy for chronic obstruc- tive pulmonary diseases in acute exacerbation period(AECOPD). Methods Selected 87 cases of patients diagnosed with AECOPD and the levels of serum PCT〉0.25 μg/L on the hospitalized day in our hospital from October 2011 to Febru ary 2013,they were randomly divided into the PCT group(53 cases) and routine treatment group (34 cases).The PCT group received antibiotic therapy according to the level of serum PCT,if the serum PCT level〈0.25 μg/L, stopped using antibiotics; the routine treatment group received antibiotic therapy according to clinical manifestation, C-reactive pro- tein,and white blood cell count.Made the sputum bacteriology examination of the two groups at the same time. Ob- served the antimicrobial treatment days,hospitalization days, clinical effective rate, aggravating or death cases, etc. Re- stilts The antimicrobial treatment days of PCT group were between 3 to 10 days in majority;while the antimicrobial treatment days of routine treatment group were more than 14 days in majority,the difference was statistical significant(P 〈 0.05); there was significant difference between the two groups in the number of double infection (P 〈 0.05);and there were no significant differences between the two groups in clinical effective rate, aggravating or death rates (P 〉 0.05). Conclusion Monitoring the level of PCT can obtain a better curative effect in the treatment of AECOPD,reduce unnecessary antibiotic use,and reduce double infection.
作者 张晨
出处 《中国现代医生》 2013年第23期64-66,共3页 China Modern Doctor
关键词 慢性阻塞性肺疾病 抗菌治疗 降钙素原 Chronic obstructive pulmonary disease Antimicrobial treatment Procalcitonin
  • 相关文献

参考文献9

  • 1Lindenauer PK, Pekow P, Cao S, et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disecase[J]. Ann Intern Med, 2006,144 (12) : 896-902.
  • 2Albrich WC,Dusemund F,Bucher B,et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract in- fections in "real life": an international,multicenter poststudy survey (ProREAL) [J]. Arch Intern Med,2012,172(17) :715-722.
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 4Becker KL,Nylen ES,White JC, et al. Clinical review 167:procalci- tonin and the Calcitonin gene family of peptides in inflammation,in- fection, and sepsis: a Journey from calcitonin back to is precursors [J]. Clin Endocrinol Metab ,2004,89(36) : 1512-1525.
  • 5Schuetz P,Christ-Crain M,Thomann R, et al. Effect of Proc~ci- tonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections:the ProHOSP randomized controlled trial[J]. JAMA, 2009,302 (2) : 1059-1066.
  • 6常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:93
  • 7Owens RC J r, Ambrose PG, Nightingale CH . Ant ibiot ie Opt imizat ion. Concepts and strategies in clinical practice[J]. New York: Marced Dekker, 2005,6 (12): 491-518.
  • 8Oezens ki W, Fitzgerald RD, Schwasrz S. Pr oeal cit on in: a new parameter for the diagnos is of bacterial infection in the peri operative period[J]. Eur J Anaestbesiol, 1998, 15(9): 202-209.
  • 9Christ-Crain M,Jaceard-Stolz D,Bingisser R , et al. Effect of Procal- eitonin-guided treatment on antibiotic use and outcome in lower res- piratory tract infections: luster-randomised,single-blinded interven- tion trial[J]. Lancet, 2004,363 (9409) : 600-607.

二级参考文献18

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med ,2002,347:465-471.
  • 3Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J,2000,19:679-688.
  • 4Stockley RA,O' Brien C ,Pye A,et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest,2000,117 : 1638-1645.
  • 5van der Valk P, Monninkhof E, van der Palen J, et al. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis,2004,39:980-986.
  • 6Pavord ID, Pizzichini MM, Pizzichini E, et al. The use of induced sputum to investigate airway inflammation. Thorax, 1997,52 : 498-501.
  • 7Pye A, Stockley RA, Hill SL. Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol,1995,48:719-724.
  • 8Anthonisen NR,Manfreda J,Warren CP,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987,106 : 196-204.
  • 9Polzin A,Pletz M,Erbes R,et al. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J,2003,21:939-943.
  • 10Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections : cluster-randomised, single-blinded intervention trial. Lancet ,2004,363:600-607.

共引文献8301

同被引文献44

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部